Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 11, 2025
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.
Journal: The oncologist
Published: November 17, 2024
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.
Journal: Cancer research communications
Published: October 02, 2024
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.
Journal: Nature medicine
Published: August 04, 2024
Sotorasib in KRAS-Mutated Colorectal Cancer. Reply.
Journal: The New England journal of medicine
Published: July 10, 2024
First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 09, 2024
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option.
Journal: Frontiers in oncology
Published: April 18, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitors.
Journal: The oncologist
Published: March 18, 2024
Comparative efficacy of PD-1 blockade in patients with dMMR/MSI-H metastatic colorectal or gastric cancer: a global retrospective study.
Journal: ESMO gastrointestinal oncology
Published: February 01, 2024
Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma.
Journal: Journal of gastric cancer
Published: December 29, 2023
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.
Journal: Journal for immunotherapy of cancer
Published: December 27, 2023
Last Updated: 09/26/2026